<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Microbiology, pathogenesis, and epidemiology of anthrax
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Microbiology, pathogenesis, and epidemiology of anthrax
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Microbiology, pathogenesis, and epidemiology of anthrax
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Kenneth H Wilson, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Daniel J Sexton, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Allyson Bloom, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Apr 10, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          Bacillus anthracis
         </em>
         , which causes anthrax, was the first clearly recognized bacterial pathogen. The life cycle of the organism was unraveled by Koch, who recognized the importance of dormant anthrax spores in the perpetuation of the organism in soil. These studies eventually helped to underpin Koch's postulates, a milestone in establishing specific pathogens as the causative agents of human and animal diseases. Pasteur created the first successful antibacterial vaccine by successfully attenuating strains of
         <em>
          B. anthracis
         </em>
         and then proving that these strains could protect sheep from infection with fully virulent strains.
        </p>
        <p>
         The microbiology, pathogenesis, and epidemiology of anthrax will be reviewed here. The clinical manifestations, diagnosis, treatment, and prevention of anthrax are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/5533.html" rel="external">
          "Clinical manifestations and diagnosis of anthrax"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/15309.html" rel="external">
          "Treatment of anthrax"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5535.html" rel="external">
          "Prevention of anthrax"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          MICROBIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          B. anthracis
         </em>
         is a sporulating gram-positive rod (
         <a class="graphic graphic_picture graphicRef58039" href="/z/d/graphic/58039.html" rel="external">
          picture 1
         </a>
         ). It is nonmotile and grows rapidly at 37ºC on blood agar plates under aerobic conditions. Individual colonies are nonhemolytic and sticky.
         <em>
          B. anthracis
         </em>
         is not phylogenetically distinct from
         <em>
          Bacillus cereus
         </em>
         and is considered a clade within the species
         <em>
          B. cereus
         </em>
         [
         <a href="#rid1">
          1
         </a>
         ]. However, because of its medical significance,
         <em>
          B. anthracis
         </em>
         retains its original species name.
        </p>
        <p>
         Molecular techniques can be used to confirm the identity of the organism, distinguishing it from
         <em>
          Bacillus thuringiensis
         </em>
         , and polymerase chain reaction techniques are highly sensitive for detecting
         <em>
          B. anthracis
         </em>
         . However, distinguishing
         <em>
          B. anthracis
         </em>
         and other clades of
         <em>
          B. cereus
         </em>
         can be difficult [
         <a href="#rid2">
          2
         </a>
         ]. Mass spectrometry appears to be a reliable method [
         <a href="#rid3">
          3,4
         </a>
         ]. Additionally, anthrax syndromes caused by strains of other members of the
         <em>
          B. cereus
         </em>
         complex that carry the pXO1 virulence plasmid have been reported [
         <a href="#rid5">
          5,6
         </a>
         ].
        </p>
        <p>
         Thus, if a
         <em>
          B. cereus
         </em>
         clade organism is isolated from a patient with a disease suggestive of anthrax, the patient should be treated for anthrax and the isolate sent to a reference lab.
        </p>
        <p>
         There is less genomic variation in
         <em>
          B. anthracis
         </em>
         than in any other known bacterial species that cause disease in humans. As a result, strain differentiation relies on finding single-nucleotide polymorphisms by whole-genome sequencing [
         <a href="#rid7">
          7
         </a>
         ], though more focused sequencing appears promising [
         <a href="#rid8">
          8
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h1">
          PATHOGENESIS
         </span>
        </p>
        <p class="headingAnchor" id="H2581166839">
         <span class="h2">
          Portals of entry and dissemination
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          B. anthracis
         </em>
         can invade the body by four routes: ingestion, transcutaneous inoculation, inhalation, and direct parenteral injection.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Gastrointestinal tract
         </strong>
         – Although disseminated anthrax frequently seeds the gastrointestinal tract [
         <a href="#rid9">
          9
         </a>
         ], the term "gastrointestinal anthrax" is used to refer to cases in which the organism gains access through ingestion. Most anthrax in nature occurs in herbivores and is acquired via the gastrointestinal route. Spores contaminating grasses are ingested. The organism then invades gut-associated lymphoid tissue, especially at Peyer's patches. An in vitro study using a cell line derived from human M cells suggests that, as in several other infections, the M cell plays a role in bacterial cell uptake [
         <a href="#rid10">
          10
         </a>
         ]. In humans, gastrointestinal anthrax follows ingestion of contaminated and undercooked meat. Following ingestion, anthrax bacilli are transported to mesenteric lymph nodes. Subsequently, hemorrhagic mesenteric adenitis, ascites, and septicemia may occur. One case was described in a patient who had played a drum made with a contaminated animal skin. An investigation suggested that the patient was exposed to
         <em>
          B. anthracis
         </em>
         spores at the drumming event, which resulted in gastrointestinal anthrax rather than inhalation anthrax [
         <a href="#rid11">
          11
         </a>
         ]. (See
         <a class="local">
          'Animal hides'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Skin
         </strong>
         – Invasion through the skin may occur via two mechanisms. Although skin abrasions were thought to be necessary for cutaneous infection, the organism also appears to be able to invade hair follicles [
         <a href="#rid12">
          12
         </a>
         ]. Once
         <em>
          B.
         </em>
         <em>
          anthracis
         </em>
         spores introduced under the skin become vegetative organisms and begin to multiply, production of an antiphagocytic capsule facilitates local spread, and exotoxin production produces marked edema and tissue necrosis. An eschar with extensive surrounding edema is the hallmark of cutaneous anthrax.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Inhalation
         </strong>
         – The classic understanding of inhalation anthrax is that spores must reach the terminal bronchioles and alveoli, where they spread to the mediastinal lymph nodes by a process that appears to involve dendritic cells [
         <a href="#rid13">
          13
         </a>
         ]. There, they germinate and induce a hemorrhagic mediastinitis before disseminating. Less frequently, inhaled spores can cause nasal, pharyngeal, or laryngeal disease or patients may present with primary meningitis, where the portal of entry is most likely the respiratory tract [
         <a href="#rid14">
          14
         </a>
         ]. Airborne anthrax spores &gt;5 microns in size pose no threat to the lungs, since they are either physically trapped in the nasopharynx or cleared by the mucociliary escalator system [
         <a href="#rid15">
          15
         </a>
         ]. Spores between 1 and 5 microns in size are deposited in alveolar ducts or alveoli. These spores are phagocytosed by alveolar macrophages and transported to mediastinal lymph nodes, where they multiply and cause hemorrhagic mediastinitis [
         <a href="#rid9">
          9,16,17
         </a>
         ]. Bacteremia is a near-universal complication of untreated mediastinal infection. Larger particles may lodge in the upper respiratory tract and cause infection, which can disseminate from that site [
         <a href="#rid18">
          18
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Direct injection
         </strong>
         – Direct injection into the host can occur when contaminated heroin is used [
         <a href="#rid19">
          19
         </a>
         ]. This has occurred by the transcutaneous route and intravenously when heroin is taken parenterally. (See
         <a class="local">
          'Injection anthrax'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p>
         Whatever the portal of entry, infection can lead to disseminated disease; if not treated early, inhalation anthrax does so in all cases. Sites of infection such as the mediastinum, the meninges, and the intestines show hemorrhagic inflammation [
         <a href="#rid20">
          20
         </a>
         ].
        </p>
        <p>
         The clinical manifestations of anthrax are discussed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/5533.html" rel="external">
          "Clinical manifestations and diagnosis of anthrax", section on 'Clinical manifestations'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H542339127">
         <span class="h2">
          Virulence factors
         </span>
         <span class="headingEndMark">
          —
         </span>
         Virulent
         <em>
          B. anthracis
         </em>
         requires a poly-D-glutamic acid capsule and three proteins (edema factor [EF], lethal factor [LF], and protective antigen [PA]) [
         <a href="#rid21">
          21
         </a>
         ]. Virulence is enhanced by the cell surface protein BslA, which mediates adhesion to host cells [
         <a href="#rid22">
          22-24
         </a>
         ]. Other virulence factors have been suggested, but induction of specific pathological events by these other factors has not been established. The organism changes its metabolism in several ways in the in vitro environment [
         <a href="#rid25">
          25
         </a>
         ].
        </p>
        <p>
         Toxin and capsule production are dependent upon the presence of two plasmids:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         pX01 (184.5 kbp) is required for the production of the components of the two exotoxins.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         pX02 (95.3 kbp) contains the genes for synthesis of the poly-D-glutamic acid capsule.
        </p>
        <p>
        </p>
        <p>
         The morbidity and mortality associated with anthrax requires the production of two toxins formed by three components: PA (protective antigen), EF (edema factor), and LF (lethal factor). EF and LF each combine with PA to form the two binary exotoxins, edema toxin (ET) and lethal toxin (LT), respectively [
         <a href="#rid26">
          26
         </a>
         ]. The PA, EF, and LF genes are under the control of the anthrax toxin activator gene (AtxA), which is encoded on pX01. The increased CO
         <sub>
          2
         </sub>
         and HCO
         <sub>
          3
         </sub>
         - concentrations of the host environment increase AtxA activity [
         <a href="#rid27">
          27
         </a>
         ]. The toxins interfere with the host response early in the infection and lead to mortality late in the infection when the bacteria have reached high concentrations in the bloodstream [
         <a href="#rid21">
          21
         </a>
         ]. The poly-D-glutamic acid capsule is antiphagocytic and weakly antigenic. Thus, strains without the pX02 plasmid are unencapsulated and are avidly phagocytosed by polymorphonuclear leukocytes [
         <a href="#rid28">
          28
         </a>
         ]. Capsule synthesis is under the indirect control of AtxA, which induces regulators that in turn control transcription of capsular synthetic genes. AtxA also regulates a variety of chromosomal genes that may form a regulatory network involved in pathogenesis [
         <a href="#rid29">
          29
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3930678789">
         <span class="h3">
          Protective antigen
         </span>
         <span class="headingEndMark">
          —
         </span>
         Protective antigen (PA) is antigenic and antibodies to it are highly protective against anthrax infection [
         <a href="#rid30">
          30
         </a>
         ]. It is the binding moiety for the two toxins and attaches to the host surface proteins ANTXR1 (tumor endothelial marker 8) and the similar ANTXR2 [
         <a href="#rid30">
          30,31
         </a>
         ]. Heterogeneity of ANTXR2 may determine different degrees of disease susceptibility [
         <a href="#rid32">
          32
         </a>
         ]. Upon attaching to the cell surface, PA is cleaved, allowing for two functions: polymerization into heptamers that form a cation-selective channel in the cell membrane and binding of LF or EF, which enter the cytosol through the channels [
         <a href="#rid33">
          33-35
         </a>
         ]. Synthetic fusion of other proteins to the N-terminal domain of LF allows them to enter the cytosol as well [
         <a href="#rid36">
          36
         </a>
         ]; this mechanism is being investigated as a means of delivering a variety of therapeutic agents to the cytosol [
         <a href="#rid37">
          37,38
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h3">
          Lethal factor and edema factor
         </span>
         <span class="headingEndMark">
          —
         </span>
         LF is a zinc metallo-protease that cleaves mitogen-activated protein (MAP) kinases 1 and 2, leading to their inactivation and inhibition of the MAP kinase signal transduction pathway [
         <a href="#rid39">
          39
         </a>
         ]. This inhibition of the MAP kinase pathway leads to inhibition of upstream signaling components that mediate nicotinamide adenine dinucleotide phosphate (NADPH) oxidase assembly.
        </p>
        <p>
         EF is a calcium-bound calmodulin-stabilized toxin that efficiently converts adenosine triphosphate (ATP) to cyclic adenosine monophosphate (cAMP) [
         <a href="#rid40">
          40,41
         </a>
         ]. The accumulation of cAMP leads to activation of the kinase A signaling pathway and thus to activation of many cellular functions.
        </p>
        <p>
         Early in infection, LF and EF interfere with innate immune functions, allowing the organism to multiply and disseminate [
         <a href="#rid21">
          21
         </a>
         ]. Early on, neutrophils, macrophages, and dendritic cells are affected. In neutrophils, recruitment, chemotaxis, priming, phagocytosis, cytokine production, and superoxide production are suppressed [
         <a href="#rid42">
          42-46
         </a>
         ]. The toxins inhibit recruitment by macrophages and mechanisms by which macrophages kill bacteria [
         <a href="#rid47">
          47,48
         </a>
         ]. Macrophages and dendritic cells succumb to activation of caspase 1 and programmed cell death [
         <a href="#rid49">
          49
         </a>
         ]. A study of organ-specific and whole-body metabolomics in mice also reflected alterations in lipid metabolism associated with dysfunction of innate immunity [
         <a href="#rid50">
          50
         </a>
         ]. As a result of effects on innate immunity,
         <em>
          B. anthracis
         </em>
         multiplies to high concentrations in lymph nodes and blood with a likely lethal outcome if this stage is reached. As an example, during the 12-hour period preceding death of guinea pigs infected with anthrax bacilli, the number of bacteria in the blood rose from 300,000 to one billion organisms/mL [
         <a href="#rid51">
          51
         </a>
         ].
        </p>
        <p>
         In late disseminated anthrax, the toxins are widely active at inaccessible intracellular locations and treatment does not assure a good outcome. Toxin levels in blood are also very high during this stage. In guinea pigs, if antibiotics are given after intravascular bacterial concentrations reach one million organisms/mL, the animals still die despite a marked reduction in these concentrations [
         <a href="#rid51">
          51
         </a>
         ]. Furthermore, sterile blood from these guinea pigs reproduces a fatal toxemic syndrome when given to normal guinea pigs. Both ET and LT lead to vascular collapse in experimental animals [
         <a href="#rid52">
          52,53
         </a>
         ]. ET induces multiorgan hemorrhage [
         <a href="#rid53">
          53
         </a>
         ]. ET and LT are toxic to essentially all cell types and study of host metabolomics indicates that many metabolic pathways are affected in vivo even early in the disease [
         <a href="#rid50">
          50
         </a>
         ], but studies in PA-receptor knockout mice have indicated which organs are the most damaged at least in mice. Intuitively, it might seem that given the hypotension and edema seen in anthrax, vascular endothelium would be a major type of tissue to fail, but this does not appear to be the case [
         <a href="#rid54">
          54
         </a>
         ]. In mice, myocardium and smooth muscle are the primary targets of LT [
         <a href="#rid55">
          55,56
         </a>
         ], but LT also induces lung injury [
         <a href="#rid57">
          57
         </a>
         ]. ET is less well studied in this model. It is thought to have widespread effects, but one study suggests that ET-induced lethality occurs via its effects on hepatocytes [
         <a href="#rid58">
          58
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h2">
          Immune response
         </span>
         <span class="headingEndMark">
          —
         </span>
         The immune response to high-level anthrax exposure was evaluated in persons exposed or possibly exposed to anthrax when a letter containing anthrax spores was sent to the Senate Office Building in the United States in 2001 [
         <a href="#rid59">
          59,60
         </a>
         ]. All of these individuals were immediately treated with antibiotics and none developed clinical anthrax, but postexposure antibiotic prophylaxis did not prevent stimulation of the immune system [
         <a href="#rid59">
          59
         </a>
         ]. Antibodies to PA and LF were present in approximately 40 and 14 percent of unvaccinated individuals, respectively, and evidence of cell-mediated immunity to PA and LF was present in about 80 and 60 percent, respectively. Although the immune responses were generally of low magnitude, there was a dose-response gradient, with immune responses primarily occurring in individuals with higher levels of exposure. (See
         <a class="local">
          'Bioterrorism'
         </a>
         below.)
        </p>
        <p>
         The presence of LF in the serum and immune responses were evaluated in 26 patients who developed cutaneous anthrax during an outbreak in Bangladesh in 2009 [
         <a href="#rid61">
          61
         </a>
         ]. LF was detected in acute serum samples from 18 of 26 individuals. Anti-PA immunoglobulin (Ig)G and lethal toxin neutralizing antibodies were detected in the sera from these 18 individuals. Seroconversion to serum anti-PA IgG and/or lethal toxin neutralizing antibodies occurred only in patients with measurable LF in the serum. Nine of the 18 patients who had LF in the serum and anti-PA IgG had received antimicrobial therapy two to seven days prior to the first sample collection, suggesting that antimicrobial use does not interfere with the development of a humoral immune response.
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h1">
          EPIDEMIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         The organism is predominantly a pathogen of mammals, but it can survive and sometimes multiply in soil [
         <a href="#rid62">
          62,63
         </a>
         ]. Despite the rarity of human cases in the current era, anthrax remains a potential threat for two reasons: anthrax epizootics still occur, and the organism remains an important potential agent of bioterrorism and biological warfare.
        </p>
        <p class="headingAnchor" id="H365640492">
         <span class="h2">
          Epizootic anthrax
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          B. anthracis
         </em>
         can be isolated from soil at sites where anthrax-infected animal carcasses have been, and, when conditions are favorable, it may propagate in soil [
         <a href="#rid63">
          63
         </a>
         ]. However, the organism is considered to be predominantly a pathogen of grazing animals; the extent to which multiplication in soil plays a role in its epidemiology is not clear.
        </p>
        <p>
         Spores can persist in the soil for decades. Surface decontamination is not practical except in unusual circumstances; thus, epizootic anthrax (ie, outbreaks in animals) will continue to occur in highly endemic areas in the developing world, where the extent of the use of animal
         <a class="drug drug_general" data-topicid="8625" href="/z/d/drug information/8625.html" rel="external">
          anthrax vaccine
         </a>
         is suboptimal [
         <a href="#rid64">
          64-67
         </a>
         ].
         <em>
          B. anthracis
         </em>
         is also endemic in agricultural regions of South and Central America, central and southwestern Asia, Africa, and southern and eastern Europe [
         <a href="#rid68">
          68
         </a>
         ].
        </p>
        <p>
         Systemic anthrax is primarily a disease of herbivores. Humans become accidentally infected through contact with infected animals, their carcasses, or their products. In the 1950s and 1960s, over 80 percent of cases in the United States were related to products that were manufactured from imported goat hair [
         <a href="#rid69">
          69
         </a>
         ]. Inhalation anthrax, or wool-sorters' disease, follows the inhalation of anthrax spores generated during the early cleaning of contaminated goat hair.
        </p>
        <p>
         During the 20
         <sup>
          th
         </sup>
         and 21
         <sup>
          st
         </sup>
         centuries, improvements in industrial hygiene, a decrease in the use of imported, contaminated animal materials, and immunization of at-risk workers resulted in a reduction in the United States incidence of inhalation anthrax (only 18 cases in the United States) [
         <a href="#rid17">
          17
         </a>
         ]. Before the 2001 bioterrorism attack, the last prior fatal case of anthrax in the United States occurred in 1976 when a weaver died of inhalational anthrax after working with yarn imported from Pakistan [
         <a href="#rid70">
          70
         </a>
         ].
        </p>
        <p>
         Epizootic anthrax cases occur rarely in the United States. In 2000, 32 farms in North Dakota in the United States were quarantined because of anthrax: a total of 157 animals died during this epizootic, and a single ranch worker who helped move dead animals developed cutaneous anthrax [
         <a href="#rid71">
          71
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H365640507">
         <span class="h3">
          Animal hides
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although the risk of anthrax associated with the handling of animal hides is low, such cases still sporadically occur [
         <a href="#rid11">
          11,72,73
         </a>
         ]. As an example, a man in Connecticut in the United States developed cutaneous anthrax in 2007 after processing a contaminated African goat hide to make a traditional drum [
         <a href="#rid73">
          73
         </a>
         ]. His eight-year-old child also developed cutaneous anthrax despite having had no direct contact with the hide. An investigation revealed widespread contamination of multiple areas of the home with
         <em>
          B. anthracis
         </em>
         , although all drum-making activities were confined to a backyard shed. In 2009, a 24-year-old woman in New Hampshire in the United States developed gastrointestinal anthrax after briefly playing a contaminated animal-hide drum [
         <a href="#rid11">
          11,74
         </a>
         ].Environmental sampling showed contamination of the drum and the environment.
        </p>
        <p class="headingAnchor" id="H515658567">
         <span class="h2">
          Injection anthrax
         </span>
         <span class="headingEndMark">
          —
         </span>
         In 2000, systemic anthrax was reported in a heroin user in Norway [
         <a href="#rid19">
          19
         </a>
         ]. There was a time gap, then an outbreak of anthrax occurred in Scotland spreading to England and Germany between December 2009 and December 2010 affecting 119 heroin users; there were 47 confirmed cases, 35 probable cases, and 37 possible cases, with 14 deaths [
         <a href="#rid75">
          75,76
         </a>
         ]. In 2012 to 2013, there were 70 cases with 26 fatalities in Denmark, France, Germany, and the United Kingdom [
         <a href="#rid77">
          77
         </a>
         ], and cases have continued to occur sporadically [
         <a href="#rid78">
          78
         </a>
         ]. Whole-genome sequencing of 60 isolates has shown multiple strains forming two closely related groups [
         <a href="#rid79">
          79
         </a>
         ]. One group was associated with the 2009 to 2010 outbreak and a different group with the 2012 to 2013 outbreak. Intriguingly, the original isolate from Norway belonged to the second group. Molecular epidemiology has made it possible to determine the geographic origin of
         <em>
          B. anthracis
         </em>
         isolates, and both clades appear to originate in the Middle East, possibly Turkey. The clinical features are discussed in greater detail separately.
        </p>
        <p class="headingAnchor" id="H447747671">
         <span class="h2">
          Bioterrorism
         </span>
         <span class="headingEndMark">
          —
         </span>
         In 2001 in the United States, 22 cases of anthrax, 18 confirmed and 4 suspected, resulted from attempts to deliberately expose selected individuals or organizations to weaponized anthrax spores [
         <a href="#rid80">
          80-84
         </a>
         ]. Eleven of these cases were inhalational and 11 cutaneous; all but two inhalational cases resulted from exposure to
         <em>
          B. anthracis
         </em>
         in a powder that had been sent through the mail, and most of the inhalational cases occurred in postal employees [
         <a href="#rid85">
          85
         </a>
         ]. Many unaffected people developed symptoms [
         <a href="#rid86">
          86
         </a>
         ], and the event was estimated to have cost the health care system USD $177 million, largely for care of people with no history of exposure [
         <a href="#rid87">
          87
         </a>
         ].
        </p>
        <p>
         Two unexpected findings resulted from the investigations of these bioterrorism cases. First, airborne dissemination of anthrax spores occurred from sealed envelopes during their travel through high-speed mail sorting machines. Second, re-aerosolization of infective spores occurred long after airborne spores had settled onto surfaces.
        </p>
        <p>
         Twenty-five days after the Senate Office Building was closed, a study was conducted in the office of a United States senator who had received an envelope that was opened by his staff [
         <a href="#rid88">
          88
         </a>
         ]. Individuals wearing sterile protective suits initially placed sampling devices around the office suite and then left the area. Later they returned to the contaminated areas and simulated office activity such as walking, sorting mail, and moving trash cans. Airborne spore concentrations increased 65-fold during the simulated active period, proving that re-aerosolization of anthrax spores is possible.
        </p>
        <p>
         Analysis of variable-number tandem repeat segments of DNA indicated that the Ames strain had been used in these attacks. This strain had been used widely by the United States military in biodefense research and distributed minimally to nonmilitary laboratories. Civilian laboratories were eliminated as the source by a criminal investigation. Comparing whole-genome single-nucleotide polymorphisms (SNPs) found in the spores sent in the mail with SNPs from laboratory samples, the United States Centers for Disease Control and Prevention (CDC) and the Federal Bureau of Investigation (FBI) implicated Bruce Ivins, a biodefense researcher working at the United States Army Medical Research Institute in Frederick, Maryland. The case was never submitted to the scrutiny of a court of law since the researcher committed suicide before the case could be tried [
         <a href="#rid89">
          89
         </a>
         ]. In 2011, a panel of experts assembled by the National Academy of Sciences evaluated the genetic analysis of the anthrax spores and advised that the scientific evidence put forth by the FBI was insufficient to prove that Ivins was the culprit [
         <a href="#rid90">
          90
         </a>
         ]. One anthrax authority and coworkers have pointed out that the spores contained large amounts of tin and silicon, probably used as a coating and possibly linking them to Dugway Proving Ground (a United States Army facility for testing biologic and chemical weapons), the source of Bruce Ivins strain in question [
         <a href="#rid91">
          91
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H442512349">
         <span class="h2">
          Laboratory incidents
         </span>
         <span class="headingEndMark">
          —
         </span>
         In March 2002, an unvaccinated laboratory worker in Texas in the United States developed cutaneous anthrax after handling agar plate cultures and anthrax-containing vials of environmental samples of
         <em>
          B. anthracis
         </em>
         as part of the investigation of the bioterrorist attack of 2001 [
         <a href="#rid92">
          92
         </a>
         ]. Although
         <em>
          B. anthracis
         </em>
         is not a highly infectious organism in the laboratory, its potential severity makes it important to carefully follow biosafety recommendations.
        </p>
        <p class="headingAnchor" id="H365640333">
         <span class="h2">
          Sverdlovsk accident
         </span>
         <span class="headingEndMark">
          —
         </span>
         An anthrax epidemic that affected both humans and livestock occurred in Sverdlovsk in the former Soviet Union in 1979 due to accidental release from a military bioweapons facility [
         <a href="#rid93">
          93
         </a>
         ]. At the time, Soviet authorities attributed the epidemic to consumption of contaminated meat. American and Russian scientists collaborated on an epidemiologic study reported in 1994, which showed the distribution of cases followed a plume that would have been explained by the prevailing wind at the time [
         <a href="#rid93">
          93
         </a>
         ]. More recently, whole-genome sequencing of anthrax genome from autopsy specimens has indicated that the strain was from Asia and had not been genetically modified [
         <a href="#rid94">
          94
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h1">
          SUMMARY
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <em>
          Bacillus anthracis
         </em>
         , which causes anthrax, was the first clearly recognized bacterial pathogen. The life cycle of the organism was unraveled by Koch, who recognized the importance of dormant anthrax spores in the perpetuation of the organism in soil. (See
         <a class="local">
          'Introduction'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <em>
          B. anthracis
         </em>
         is a sporulating gram-positive rod. Virulent
         <em>
          B. anthracis
         </em>
         requires a poly-D-glutamic acid capsule and three proteins (edema factor [EF], lethal factor [LF], and protective antigen [PA]) that associate into two protein exotoxins. (See
         <a class="local">
          'Pathogenesis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <em>
          B. anthracis
         </em>
         has the potential to invade the body by four routes: ingestion, transcutaneous inoculation, inhalation, and direct parenteral injection. Whatever the portal of entry, infection can lead to disseminated disease; if not treated early, inhalation anthrax does so in all cases. (See
         <a class="local">
          'Portals of entry and dissemination'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Gastrointestinal anthrax follows ingestion of contaminated and undercooked meat. Following ingestion, anthrax bacilli are transported to mesenteric lymph nodes. Subsequently, hemorrhagic mesenteric adenitis, ascites, and septicemia may occur. (See
         <a class="local">
          'Portals of entry and dissemination'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         When introduced subcutaneously, spores of virulent
         <em>
          B. anthracis
         </em>
         become vegetative organisms and begin to multiply. Subsequent production of an antiphagocytic capsule facilitates local spread, and exotoxin production produces marked edema and tissue necrosis. An eschar with extensive surrounding edema is the hallmark of cutaneous anthrax. (See
         <a class="local">
          'Portals of entry and dissemination'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Spores between 1 and 5 microns in size are deposited in alveolar ducts or alveoli. Larger groupings of spores are usually filtered out or trapped by the mucociliary tree and can cause infection of the nasal passage, pharynx, and larynx. Spores in the lung are phagocytosed by alveolar macrophages and transported to mediastinal lymph nodes, where they multiply and cause a hemorrhagic mediastinitis. Bacteremia is a near-universal complication after mediastinal infection has become established. (See
         <a class="local">
          'Portals of entry and dissemination'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The organism's major ecologic niche is as a pathogen of herbivores. It also may be able to propagate in soil. Humans become accidentally infected through contact with infected animals or their products. (See
         <a class="local">
          'Epidemiology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In 2001 in the United States, 22 cases of anthrax, 18 confirmed and 4 suspected, resulted from attempts to deliberately expose selected individuals or organizations to weaponized anthrax spores. Eleven of these cases were inhalational and 11 cutaneous; all but two inhalational cases resulted from direct exposure to
         <em>
          B. anthracis
         </em>
         in a powder that had been sent through the mail, and most of the inhalational cases occurred in postal employees. (See
         <a class="local">
          'Bioterrorism'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Large outbreaks of anthrax occurred in heroin users in Europe in 2009 to 2010 and 2012 to 2013, causing skin and soft tissue infections in most patients. Additional cases have been reported in heroin users in Europe subsequently. Two separate contamination events appear to have occurred. (See
         <a class="local">
          'Injection anthrax'
         </a>
         above.)
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Van der Auwera GA, Feldgarden M, Kolter R, Mahillon J. Whole-Genome Sequences of 94 Environmental Isolates of Bacillus cereus Sensu Lato. Genome Announc 2013; 1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Carroll LM, Wiedmann M, Kovac J. Proposal of a Taxonomic Nomenclature for the Bacillus cereus Group Which Reconciles Genomic Definitions of Bacterial Species with Clinical and Industrial Phenotypes. mBio 2020; 11.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wei J, Zhang H, Zhang H, et al. Novel Strategy for Rapidly and Safely Distinguishing Bacillus anthracis and Bacillus cereus by Use of Peptide Mass Fingerprints Based on Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry. J Clin Microbiol 2020; 59.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Manzulli V, Rondinone V, Buchicchio A, et al. Discrimination of Bacillus cereus Group Members by MALDI-TOF Mass Spectrometry. Microorganisms 2021; 9.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hendricks K, Martines RB, Bielamowicz H, et al. Welder's Anthrax: A Tale of 2 Cases. Clin Infect Dis 2022; 75:S354.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dawson P, Schrodt CA, Feldmann K, et al. Notes from the Field: Fatal Anthrax Pneumonia in Welders and Other Metalworkers Caused by Bacillus cereus Group Bacteria Containing Anthrax Toxin Genes - U.S. Gulf Coast States, 1994-2020. MMWR Morb Mortal Wkly Rep 2021; 70:1453.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Read TD, Salzberg SL, Pop M, et al. Comparative genome sequencing for discovery of novel polymorphisms in Bacillus anthracis. Science 2002; 296:2028.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Abdel-Glil MY, Chiaverini A, Garofolo G, et al. A Whole-Genome-Based Gene-by-Gene Typing System for Standardized High-Resolution Strain Typing of Bacillus anthracis. J Clin Microbiol 2021; 59:e0288920.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Abramova FA, Grinberg LM, Yampolskaya OV, Walker DH. Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979. Proc Natl Acad Sci U S A 1993; 90:2291.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tonry JH, Popov SG, Narayanan A, et al. In vivo murine and in vitro M-like cell models of gastrointestinal anthrax. Microbes Infect 2013; 15:37.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Centers for Disease Control and Prevention (CDC). Gastrointestinal anthrax after an animal-hide drumming event - New Hampshire and Massachusetts, 2009. MMWR Morb Mortal Wkly Rep 2010; 59:872.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zakowska D, Bartoszcze M, Niemcewicz M, et al. New aspects of the infection mechanisms of Bacillus anthracis. Ann Agric Environ Med 2012; 19:613.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shetron-Rama LM, Herring-Palmer AC, Huffnagle GB, Hanna P. Transport of Bacillus anthracis from the lungs to the draining lymph nodes is a rapid process facilitated by CD11c+ cells. Microb Pathog 2010; 49:38.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Holty JE, Kim RY, Bravata DM. Anthrax: a systematic review of atypical presentations. Ann Emerg Med 2006; 48:200.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           DRUETT HA, HENDERSON DW, PACKMAN L, PEACOCK S. Studies on respiratory infection. I. The influence of particle size on respiratory infection with anthrax spores. J Hyg (Lond) 1953; 51:359.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dalldorf FG, Kaufmann AF, Brachman PS. Woolsorters' disease. An experimental model. Arch Pathol 1971; 92:418.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brachman PS. Inhalation anthrax. Ann N Y Acad Sci 1980; 353:83.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thomas R, Davies C, Nunez A, et al. Influence of particle size on the pathology and efficacy of vaccination in a murine model of inhalational anthrax. J Med Microbiol 2010; 59:1415.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ringertz SH, Høiby EA, Jensenius M, et al. Injectional anthrax in a heroin skin-popper. Lancet 2000; 356:1574.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Abramova AA, Grinberg LM. [Pathology of anthrax sepsis according to materials of the infectious outbreak in 1979 in Sverdlovsk (macroscopic changes)]. Arkh Patol 1993; 55:12.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moayeri M, Leppla SH, Vrentas C, et al. Anthrax Pathogenesis. Annu Rev Microbiol 2015; 69:185.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ebrahimi CM, Kern JW, Sheen TR, et al. Penetration of the blood-brain barrier by Bacillus anthracis requires the pXO1-encoded BslA protein. J Bacteriol 2009; 191:7165.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kern J, Schneewind O. BslA, the S-layer adhesin of B. anthracis, is a virulence factor for anthrax pathogenesis. Mol Microbiol 2010; 75:324.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wang Y, Wei Y, Yuan S, et al. Bacillus anthracis S-layer protein BslA binds to extracellular matrix by interacting with laminin. BMC Microbiol 2016; 16:183.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Laut CL, Leasure CS, Pi H, et al. DnaJ and ClpX Are Required for HitRS and HssRS Two-Component System Signaling in Bacillus anthracis. Infect Immun 2022; 90:e0056021.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dixon TC, Meselson M, Guillemin J, Hanna PC. Anthrax. N Engl J Med 1999; 341:815.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hammerstrom TG, Roh JH, Nikonowicz EP, Koehler TM. Bacillus anthracis virulence regulator AtxA: oligomeric state, function and CO(2) -signalling. Mol Microbiol 2011; 82:634.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mikesell P, Ivins BE, Ristroph JD, et al. Plasmids, Pasteur, and anthrax. ASM News 1983; 7:320.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Furuta Y, Cheng C, Zorigt T, et al. Direct Regulons of AtxA, the Master Virulence Regulator of Bacillus anthracis. mSystems 2021; 6:e0029121.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bradley KA, Mogridge J, Mourez M, et al. Identification of the cellular receptor for anthrax toxin. Nature 2001; 414:225.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Scobie HM, Rainey GJ, Bradley KA, Young JA. Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor. Proc Natl Acad Sci U S A 2003; 100:5170.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ramachandran G, Gade P, Tsai P, et al. Potential role of autophagy in the bactericidal activity of human PMNs for Bacillus anthracis. Pathog Dis 2015; 73:ftv080.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Singh Y, Klimpel KR, Arora N, et al. The chymotrypsin-sensitive site, FFD315, in anthrax toxin protective antigen is required for translocation of lethal factor. J Biol Chem 1994; 269:29039.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mogridge J, Cunningham K, Lacy DB, et al. The lethal and edema factors of anthrax toxin bind only to oligomeric forms of the protective antigen. Proc Natl Acad Sci U S A 2002; 99:7045.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Blaustein RO, Koehler TM, Collier RJ, Finkelstein A. Anthrax toxin: channel-forming activity of protective antigen in planar phospholipid bilayers. Proc Natl Acad Sci U S A 1989; 86:2209.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Arora N, Leppla SH. Residues 1-254 of anthrax toxin lethal factor are sufficient to cause cellular uptake of fused polypeptides. J Biol Chem 1993; 268:3334.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Liu W, Nestorovich EM. Anthrax toxin channel: What we know based on over 30 years of research. Biochim Biophys Acta Biomembr 2021; 1863:183715.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hirschenberger M, Stadler N, Fellermann M, et al. CRISPA: A Non-viral, Transient Cas9 Delivery System Based on Reengineered Anthrax Toxin. Front Pharmacol 2021; 12:770283.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Duesbery NS, Webb CP, Leppla SH, et al. Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science 1998; 280:734.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leppla SH. Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells. Proc Natl Acad Sci U S A 1982; 79:3162.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leppla SH. Bacillus anthracis calmodulin-dependent adenylate cyclase: chemical and enzymatic properties and interactions with eucaryotic cells. Adv Cyclic Nucleotide Protein Phosphorylation Res 1984; 17:189.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           During RL, Li W, Hao B, et al. Anthrax lethal toxin paralyzes neutrophil actin-based motility. J Infect Dis 2005; 192:837.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weiner ZP, Ernst SM, Boyer AE, et al. Circulating lethal toxin decreases the ability of neutrophils to respond to Bacillus anthracis. Cell Microbiol 2014; 16:504.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           O'Brien J, Friedlander A, Dreier T, et al. Effects of anthrax toxin components on human neutrophils. Infect Immun 1985; 47:306.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barson HV, Mollenkopf H, Kaufmann SH, Rijpkema S. Anthrax lethal toxin suppresses chemokine production in human neutrophil NB-4 cells. Biochem Biophys Res Commun 2008; 374:288.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Crawford MA, Aylott CV, Bourdeau RW, Bokoch GM. Bacillus anthracis toxins inhibit human neutrophil NADPH oxidase activity. J Immunol 2006; 176:7557.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Park JM, Greten FR, Li ZW, Karin M. Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition. Science 2002; 297:2048.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alileche A, Serfass ER, Muehlbauer SM, et al. Anthrax lethal toxin-mediated killing of human and murine dendritic cells impairs the adaptive immune response. PLoS Pathog 2005; 1:e19.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fink SL, Bergsbaken T, Cookson BT. Anthrax lethal toxin and Salmonella elicit the common cell death pathway of caspase-1-dependent pyroptosis via distinct mechanisms. Proc Natl Acad Sci U S A 2008; 105:4312.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nguyen CT, Shetty V, Maresso AW. Global metabolomic analysis of a mammalian host infected with Bacillus anthracis. Infect Immun 2015; 83:4811.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           KEPPIE J, SMITH H, HARRIS-SMITH PW. The chemical basis of the virulence of Bacillus anthracis. III. The role of the terminal bacteraemia in death of guinea-pigs from anthrax. Br J Exp Pathol 1955; 36:315.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hanna P. Lethal toxin actions and their consequences. J Appl Microbiol 1999; 87:285.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Firoved AM, Miller GF, Moayeri M, et al. Bacillus anthracis edema toxin causes extensive tissue lesions and rapid lethality in mice. Am J Pathol 2005; 167:1309.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Liu S, Zhang Y, Moayeri M, et al. Key tissue targets responsible for anthrax-toxin-induced lethality. Nature 2013; 501:63.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Beall FA, Dalldorf FG. The pathogenesis of the lethal effect of anthrax toxin in the rat. J Infect Dis 1966; 116:377.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hicks CW, Li Y, Okugawa S, et al. Anthrax edema toxin has cAMP-mediated stimulatory effects and high-dose lethal toxin has depressant effects in an isolated perfused rat heart model. Am J Physiol Heart Circ Physiol 2011; 300:H1108.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lehmann M, Noack D, Wood M, et al. Lung epithelial injury by B. anthracis lethal toxin is caused by MKK-dependent loss of cytoskeletal integrity. PLoS One 2009; 4:e4755.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cui X, Li Y, Li X, et al. Bacillus anthracis edema and lethal toxin have different hemodynamic effects but function together to worsen shock and outcome in a rat model. J Infect Dis 2007; 195:572.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Doolan DL, Freilich DA, Brice GT, et al. The US capitol bioterrorism anthrax exposures: clinical epidemiological and immunological characteristics. J Infect Dis 2007; 195:174.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hadler JL. Learning from the 2001 anthrax attacks: immunological characteristics. J Infect Dis 2007; 195:163.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boyer AE, Quinn CP, Beesley CA, et al. Lethal factor toxemia and anti-protective antigen antibody activity in naturally acquired cutaneous anthrax. J Infect Dis 2011; 204:1321.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Titball RW, Turnbull PC, Hutson RA. The monitoring and detection of Bacillus anthracis in the environment. Soc Appl Bacteriol Symp Ser 1991; 20:9S.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Braun P, Grass G, Aceti A, et al. Microevolution of Anthrax from a Young Ancestor (M.A.Y.A.) Suggests a Soil-Borne Life Cycle of Bacillus anthracis. PLoS One 2015; 10:e0135346.
          </a>
         </li>
         <li class="breakAll">
          Programme on Infectious Disease and Vaccine Sciences, ICDDR,B and Institute of Epidemiology, Disease Control and Research (IEDCR), Ministry of Health and Family Welfare, Department of Livestock Services (DLS), Government of the People's Republic of Bangladesh. Cutaneous anthrax outbreaks in two districts of North-Western Bangladesh, August-October 2009. Health and Science Bulletin December 2009. Bangladesh: International Centre for Diarrhoeal Disease Research, 2009. http://www.icddrb.org/what-we-do/publications/cat_view/52-publications/10042-icddrb-periodicals/10048-health-and-science-bulletin-bangla-and-english/10261-vol-7-no-4-english-2009/11766-cutaneous-anthrax-outbreaks-in-two-districts-of-north-western-bangladesh-august-october-2009 (Accessed on January 16, 2012).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Navdarashvili A, Doker TJ, Geleishvili M, et al. Human anthrax outbreak associated with livestock exposure: Georgia, 2012. Epidemiol Infect 2016; 144:76.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chen WJ, Lai SJ, Yang Y, et al. Mapping the Distribution of Anthrax in Mainland China, 2005-2013. PLoS Negl Trop Dis 2016; 10:e0004637.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Patassi AA, Saka B, Landoh DE, et al. Detection and management of the first human anthrax outbreak in Togo. Trop Doct 2016; 46:129.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hendricks KA, Wright ME, Shadomy SV, et al. Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults. Emerg Infect Dis 2014; 20.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brachman PS. Human anthrax in the United States. Antimicrob Agents Chemother (Bethesda) 1965; 5:111.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Suffin SC, Carnes WH, Kaufmann AF. Inhalation anthrax in a home craftsman. Hum Pathol 1978; 9:594.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Centers for Disease Control and Prevention (CDC). Human anthrax associated with an epizootic among livestock--North Dakota, 2000. MMWR Morb Mortal Wkly Rep 2001; 50:677.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Centers for Disease Control and Prevention (CDC). Inhalation anthrax associated with dried animal hides--Pennsylvania and New York City, 2006. MMWR Morb Mortal Wkly Rep 2006; 55:280.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Centers for Disease Control and Prevention (CDC). Cutaneous anthrax associated with drum making using goat hides from West Africa--Connecticut, 2007. MMWR Morb Mortal Wkly Rep 2008; 57:628.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Klempner MS, Talbot EA, Lee SI, et al. Case records of the Massachusetts General Hospital. Case 25-2010. A 24-year-old woman with abdominal pain and shock. N Engl J Med 2010; 363:766.
          </a>
         </li>
         <li class="breakAll">
          Health Protection Scotland. An outbreak of anthrax among drug users in Scotland, December 2009 to December 2010. A report on behalf of the National Anthrax Outbreak Control Team. http://www.documents.hps.scot.nhs.uk/giz/anthrax-outbreak/anthrax-outbreak-report-2011-12.pdf (Accessed on January 16, 2012).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Price EP, Seymour ML, Sarovich DS, et al. Molecular epidemiologic investigation of an anthrax outbreak among heroin users, Europe. Emerg Infect Dis 2012; 18:1307.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Berger T, Kassirer M, Aran AA. Injectional anthrax - new presentation of an old disease. Euro Surveill 2014; 19.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Inverarity DJ, Forrester VM, Cumming JG, et al. Injectional anthrax at a Scottish district general hospital. Epidemiol Infect 2015; 143:1311.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Keim P, Grunow R, Vipond R, et al. Whole Genome Analysis of Injectional Anthrax Identifies Two Disease Clusters Spanning More Than 13 Years. EBioMedicine 2015; 2:1613.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Notice to readers: Ongoing investigation of anthrax--Florida, October 2001. MMWR Morb Mortal Wkly Rep 2001; 50:877.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bush LM, Abrams BH, Beall A, Johnson CC. Index case of fatal inhalational anthrax due to bioterrorism in the United States. N Engl J Med 2001; 345:1607.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Centers for Disease Control and Prevention (CDC). Update: Investigation of anthrax associated with intentional exposure and interim public health guidelines, October 2001. MMWR Morb Mortal Wkly Rep 2001; 50:889.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Centers for Disease Control and Prevention (CDC). Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001. MMWR Morb Mortal Wkly Rep 2001; 50:909.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Centers for Disease Control and Prevention (CDC). Update: Investigation of bioterrorism-related anthrax--Connecticut, 2001. MMWR Morb Mortal Wkly Rep 2001; 50:1077.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jernigan DB, Raghunathan PL, Bell BP, et al. Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg Infect Dis 2002; 8:1019.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chiao S, Kipen H, Hallman WK, et al. Anthrax Exposure, Belief in Exposure, and Postanthrax Symptoms Among Survivors of a Bioterrorist Attack on Capitol Hill. Disaster Med Public Health Prep 2019; 13:555.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zacchia NA, Schmitt K. Medical Spending for the 2001 Anthrax Letter Attacks. Disaster Med Public Health Prep 2019; 13:539.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weis CP, Intrepido AJ, Miller AK, et al. Secondary aerosolization of viable Bacillus anthracis spores in a contaminated US Senate Office. JAMA 2002; 288:2853.
          </a>
         </li>
         <li class="breakAll">
          Bhattacharjee Y. FBI Anthrax Investigation Under Scientific Review, May 6, 2009. Science Insider. http://blogs.sciencemag.org/scienceinsider/2009/05/fbi-anthrax-inv.html (Accessed on June 09, 2009).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bush LM, Perez MT. The anthrax attacks 10 years later. Ann Intern Med 2012; 156:41.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hugh-Jones ME, Rosenberg BH, Jacobsen S. Evidence for the source of the 2001 attack anthrax. J Bioterr Biodef 2012; S3:008.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Centers for Disease Control and Prevention (CDC). Suspected cutaneous anthrax in a laboratory worker--Texas, 2002. MMWR Morb Mortal Wkly Rep 2002; 51:279.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Meselson M, Guillemin J, Hugh-Jones M, et al. The Sverdlovsk anthrax outbreak of 1979. Science 1994; 266:1202.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sahl JW, Pearson T, Okinaka R, et al. A Bacillus anthracis Genome Sequence from the Sverdlovsk 1979 Autopsy Specimens. mBio 2016; 7.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 5506 Version 21.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24092776" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Whole-Genome Sequences of 94 Environmental Isolates of Bacillus cereus Sensu Lato.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32098810" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Proposal of a Taxonomic Nomenclature for the Bacillus cereus Group Which Reconciles Genomic Definitions of Bacterial Species with Clinical and Industrial Phenotypes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33115846" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Novel Strategy for Rapidly and Safely Distinguishing Bacillus anthracis and Bacillus cereus by Use of Peptide Mass Fingerprints Based on Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34199368" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Discrimination of Bacillus cereus Group Members by MALDI-TOF Mass Spectrometry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36251561" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Welder's Anthrax: A Tale of 2 Cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34648482" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Notes from the Field: Fatal Anthrax Pneumonia in Welders and Other Metalworkers Caused by Bacillus cereus Group Bacteria Containing Anthrax Toxin Genes - U.S. Gulf Coast States, 1994-2020.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12004073" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Comparative genome sequencing for discovery of novel polymorphisms in Bacillus anthracis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33827898" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : A Whole-Genome-Based Gene-by-Gene Typing System for Standardized High-Resolution Strain Typing of Bacillus anthracis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8460135" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23108317" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : In vivo murine and in vitro M-like cell models of gastrointestinal anthrax.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20651643" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Gastrointestinal anthrax after an animal-hide drumming event - New Hampshire and Massachusetts, 2009.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23311776" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : New aspects of the infection mechanisms of Bacillus anthracis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20188814" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Transport of Bacillus anthracis from the lungs to the draining lymph nodes is a rapid process facilitated by CD11c+ cells.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16857469" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Anthrax: a systematic review of atypical presentations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/13096744" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Studies on respiratory infection. I. The influence of particle size on respiratory infection with anthrax spores.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5001047" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Woolsorters' disease. An experimental model.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7013615" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Inhalation anthrax.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20798216" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Influence of particle size on the pathology and efficacy of vaccination in a murine model of inhalational anthrax.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11075776" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Injectional anthrax in a heroin skin-popper.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7980032" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : [Pathology of anthrax sepsis according to materials of the infectious outbreak in 1979 in Sverdlovsk (macroscopic changes)].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26195305" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Anthrax Pathogenesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19820089" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Penetration of the blood-brain barrier by Bacillus anthracis requires the pXO1-encoded BslA protein.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19906175" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : BslA, the S-layer adhesin of B. anthracis, is a virulence factor for anthrax pathogenesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27514510" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Bacillus anthracis S-layer protein BslA binds to extracellular matrix by interacting with laminin.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34748369" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : DnaJ and ClpX Are Required for HitRS and HssRS Two-Component System Signaling in Bacillus anthracis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10477781" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Anthrax.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21923765" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Bacillus anthracis virulence regulator AtxA: oligomeric state, function and CO(2) -signalling.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Plasmids, Pasteur, and anthrax
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34282944" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Direct Regulons of AtxA, the Master Virulence Regulator of Bacillus anthracis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11700562" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Identification of the cellular receptor for anthrax toxin.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12700348" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26424808" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Potential role of autophagy in the bactericidal activity of human PMNs for Bacillus anthracis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7961869" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : The chymotrypsin-sensitive site, FFD315, in anthrax toxin protective antigen is required for translocation of lethal factor.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11997437" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : The lethal and edema factors of anthrax toxin bind only to oligomeric forms of the protective antigen.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2467303" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Anthrax toxin: channel-forming activity of protective antigen in planar phospholipid bilayers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8429009" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Residues 1-254 of anthrax toxin lethal factor are sufficient to cause cellular uptake of fused polypeptides.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34332985" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Anthrax toxin channel: What we know based on over 30 years of research.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34733166" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : CRISPA: A Non-viral, Transient Cas9 Delivery System Based on Reengineered Anthrax Toxin.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9563949" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6285339" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6328915" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Bacillus anthracis calmodulin-dependent adenylate cyclase: chemical and enzymatic properties and interactions with eucaryotic cells.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16088833" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Anthrax lethal toxin paralyzes neutrophil actin-based motility.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24152301" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Circulating lethal toxin decreases the ability of neutrophils to respond to Bacillus anthracis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3917427" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Effects of anthrax toxin components on human neutrophils.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18625197" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Anthrax lethal toxin suppresses chemokine production in human neutrophil NB-4 cells.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16751402" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Bacillus anthracis toxins inhibit human neutrophil NADPH oxidase activity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12202685" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16254597" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Anthrax lethal toxin-mediated killing of human and murine dendritic cells impairs the adaptive immune response.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18337499" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Anthrax lethal toxin and Salmonella elicit the common cell death pathway of caspase-1-dependent pyroptosis via distinct mechanisms.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26438791" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Global metabolomic analysis of a mammalian host infected with Bacillus anthracis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/13239988" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : The chemical basis of the virulence of Bacillus anthracis. III. The role of the terminal bacteraemia in death of guinea-pigs from anthrax.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10475969" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Lethal toxin actions and their consequences.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16251415" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Bacillus anthracis edema toxin causes extensive tissue lesions and rapid lethality in mice.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23995686" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Key tissue targets responsible for anthrax-toxin-induced lethality.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4957317" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : The pathogenesis of the lethal effect of anthrax toxin in the rat.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21217068" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Anthrax edema toxin has cAMP-mediated stimulatory effects and high-dose lethal toxin has depressant effects in an isolated perfused rat heart model.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19270742" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Lung epithelial injury by B. anthracis lethal toxin is caused by MKK-dependent loss of cytoskeletal integrity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17230417" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Bacillus anthracis edema and lethal toxin have different hemodynamic effects but function together to worsen shock and outcome in a rat model.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17191162" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : The US capitol bioterrorism anthrax exposures: clinical epidemiological and immunological characteristics.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17191158" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Learning from the 2001 anthrax attacks: immunological characteristics.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21908727" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Lethal factor toxemia and anti-protective antigen antibody activity in naturally acquired cutaneous anthrax.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1909461" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : The monitoring and detection of Bacillus anthracis in the environment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26266934" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Microevolution of Anthrax from a Young Ancestor (M.A.Y.A.) Suggests a Soil-Borne Life Cycle of Bacillus anthracis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26266934" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Microevolution of Anthrax from a Young Ancestor (M.A.Y.A.) Suggests a Soil-Borne Life Cycle of Bacillus anthracis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26088361" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Human anthrax outbreak associated with livestock exposure: Georgia, 2012.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27097318" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Mapping the Distribution of Anthrax in Mainland China, 2005-2013.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26672006" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Detection and management of the first human anthrax outbreak in Togo.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24447897" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5883410" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Human anthrax in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/101438" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Inhalation anthrax in a home craftsman.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11785567" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Human anthrax associated with an epizootic among livestock--North Dakota, 2000.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16543883" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Inhalation anthrax associated with dried animal hides--Pennsylvania and New York City, 2006.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18551098" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Cutaneous anthrax associated with drum making using goat hides from West Africa--Connecticut, 2007.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20818879" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Case records of the Massachusetts General Hospital. Case 25-2010. A 24-year-old woman with abdominal pain and shock.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20818879" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Case records of the Massachusetts General Hospital. Case 25-2010. A 24-year-old woman with abdominal pain and shock.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22840345" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Molecular epidemiologic investigation of an anthrax outbreak among heroin users, Europe.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25139073" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Injectional anthrax - new presentation of an old disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25078285" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Injectional anthrax at a Scottish district general hospital.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26870786" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Whole Genome Analysis of Injectional Anthrax Identifies Two Disease Clusters Spanning More Than 13 Years.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Notice to readers: Ongoing investigation of anthrax--Florida, October 2001
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11704685" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Index case of fatal inhalational anthrax due to bioterrorism in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11686472" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Update: Investigation of anthrax associated with intentional exposure and interim public health guidelines, October 2001.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11699843" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11770501" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Update: Investigation of bioterrorism-related anthrax--Connecticut, 2001.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12396909" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30417804" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Anthrax Exposure, Belief in Exposure, and Postanthrax Symptoms Among Survivors of a Bioterrorist Attack on Capitol Hill.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30417803" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Medical Spending for the 2001 Anthrax Letter Attacks.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12472327" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Secondary aerosolization of viable Bacillus anthracis spores in a contaminated US Senate Office.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12472327" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Secondary aerosolization of viable Bacillus anthracis spores in a contaminated US Senate Office.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21969275" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : The anthrax attacks 10 years later.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Evidence for the source of the 2001 attack anthrax
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11952281" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Suspected cutaneous anthrax in a laboratory worker--Texas, 2002.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7973702" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : The Sverdlovsk anthrax outbreak of 1979.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27677796" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : A Bacillus anthracis Genome Sequence from the Sverdlovsk 1979 Autopsy Specimens.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
